SCHEMBL38494

SCHEMBL38494

CC#CC(N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11830007 0.75
SCHEMBL759891 0.72
SCHEMBL8284153 0.72
SCHEMBL28146625 0.69
SCHEMBL17226361 0.69
Hydrochloric Acid SCHEMBL2214173 0.69
Hydrochloric Acid SCHEMBL15561475 0.69
SCHEMBL6586016 0.67
Hydrochloric Acid SCHEMBL7446780 0.67
SCHEMBL22097676 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143028-A2 LOW DIELECTRIC CONSTANT MATERIALS PREPARED FROM SOLUBLE FULLERENE CLUSTERS ROSKILDE SEMICONDUCTOR LLC (US) 2007-12-13 WO claimed
US-12440584-B2 Macrocyclic ligands with pendant chelating moieties and complexes thereof LUMIPHORE, INC. (US) 2025-10-14 US disclosed
US-20250090696-A1 MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF LUMIPHORE, INC. 2025-03-20 US disclosed
CN-118382612-A Method for producing blocked isocyanate compound and method for producing isocyanate compound 旭化成株式会社 2024-07-23 CN disclosed
US-11951188-B2 Macrocyclic ligands with pendant chelating moieties and complexes thereof LUMIPHORE, INC. (US) 2024-04-09 US disclosed
US-20240067650-A1 MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF LUMIPHORE, INC. 2024-02-29 US disclosed
US-11603371-B2 Macrocyclic ligands with pendant chelating moieties and complexes thereof LUMIPHORE, INC. (US) 2023-03-14 US disclosed
EP-3199533-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2017-08-02 EP disclosed
US-20160052863-A1 PROCESS FOR PRODUCING AN AMINOPROPYNE OR ENAMINONE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-02-25 US disclosed
US-9193668-B2 Process for producing an aminopropyne or enaminone AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-11-24 US disclosed
EP-2729442-A1 PROCESS FOR PRODUCING AN AMINOPROPYNE OR ENAMINONE Agency For Science, Technology And Research (SG) 2014-05-14 EP disclosed
EP-2651919-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-10-23 EP disclosed
EP-2651917-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-10-23 EP disclosed
WO-2013006143-A1 PROCESS FOR PRODUCING AN AMINOPROPYNE OR ENAMINONE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-01-10 WO disclosed
EP-2539333-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-01-02 EP disclosed
WO-2012080260-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2012-06-21 WO disclosed
WO-2012080271-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2012-06-21 WO disclosed
WO-2012005692-A1 PROPARGYLAMINE SYNTHESIS USING A COPPER (I) CATALYSED THREE COMPONENT COUPLING REACTION AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-01-12 WO disclosed
WO-2011104266-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2011-09-01 WO disclosed
WO-2007143028-A2 LOW DIELECTRIC CONSTANT MATERIALS PREPARED FROM SOLUBLE FULLERENE CLUSTERS ROSKILDE SEMICONDUCTOR LLC (US) 2007-12-13 WO disclosed